Previous studies revealed that an intraperitoneal, intravitreal, or subcutaneous injection of HSP27 leads to glaucoma-like damage in young rats (Wax et al., 2008; Grotegut et al., 2020; Zhao et al., 2020). This evidence concerns the gene HSPB2 and glaucoma.